Zobrazeno 1 - 9
of 9
pro vyhledávání: '"Rasha A Alshaikh"'
Objective: To explore the role of parent awareness in dental caries and follow-up treatment required for healing with oral issues. Methods: The research was conducted through cross- a sectional research design. This type of research design helps meas
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6151dc3a321c2a7aaa888c877d707e6d
Autor:
Rasha A Alshaikh, Rania Gamal Eldin Zaki, Rania A Salah El Din, Katie B Ryan, Christian Waeber
Publikováno v:
Journal of Pharmacology and Experimental Therapeutics. :JPET-AR
Autor:
Fotouh R. Mansour, Hala Raaft, Ahmed A Ibrahim, Kholoud Ayman, Ahmed Elbardakheny, Soad S Mandoh, Rasha A. Alshaikh
Publikováno v:
Virusdisease
Hepatitis C is a viral infection that has been declared as a global health problem by the World Health Organization. Egypt has the highest prevalence of hepatitis C virus (HCV) which results in a high morbidity and mortality from chronic liver diseas
Publikováno v:
International Journal of Pharmaceutics. 563:395-405
Fast dissolution of nonsteroidal anti-inflammatory drugs (NSAIDs) is a prerequisite from patient perspective. However, most NSAIDs are slowly dissolving acidic compounds. Caffeine, a commonly used analgesic adjuvant with NSAIDs showed high potential
Publikováno v:
Advanced Drug Delivery Reviews. 187:114342
There is an increasing momentum in research and pharmaceutical industry communities to design sustained, non-invasive delivery systems to treat chronic neovascular ocular diseases that affect the posterior segment of the eye including age-related mac
Publikováno v:
The British journal of ophthalmology. 106(9)
Neovascular ocular diseases (such as age-related macular degeneration, diabetic retinopathy and retinal vein occlusion) are characterised by common pathological processes that contribute to disease progression. These include angiogenesis, oedema, inf
Publikováno v:
AAPS PharmSciTech. 22
Development of fixed dose combinations is growing and many of these drug combinations are being legally marketed. However, the development of these requires careful investigation of possible physicochemical changes during co-processing. This requires
Publikováno v:
AAPS PharmSciTech. 22(2)
Development of fixed dose combinations is growing and many of these drug combinations are being legally marketed. However, the development of these requires careful investigation of possible physicochemical changes during co-processing. This requires
Publikováno v:
Pharmaceutical development and technology. 25(2)
Fenofibrate is antihyperlipidemic which has low and variable oral bioavailability due to erratic dissolution characteristics. Niacin showed a potential atheroprotective effects suggesting possible co-administration with fenofibrate with a potential f